MURRIETA, CA--(Marketwire - September 25, 2008) - CLX Medical, Inc. (OTCBB: CLXN) CEO Vera Leonard today commented on the opportunities presented by the acquisition of ThyroTest®, a rapid thyroid stimulating hormone (TSH) screening device used for the detection of hypothyroidism in adults, a common thyroid disease.
